Market header image

Bulletins

You are here

2019-0810 - Suspension Extension - Abattis Bioceuticals Corp. (ATT)

le 9 août/August 2019

Further to bulletin 2019-0808 - Delist - Abattis Bioceuticals Corp. (ATT) the common shares of the company will not be delisted at market close but remain suspended.

For further information please view the company's press release.

  ___________________________

Suite au bulletin 2019-0808 - Retrait- Abattis Bioceuticals Corp. (ATT), les actions ordinaires de la société ne seront pas radiées de la cote à la clôture du marché, mais resteront suspendues.
Pour plus d'informations, veuillez consulter le communiqué de presse de l'entreprise.

Symbol(s)/Symbole(s): ATT

 

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse:  Listings@thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

02_24_Benzinga_Cannabis_Capital_Conference_Miami_Website

Benzinga Cannabis Capital Conference Miami

Monday, February 24, 2020 (All day) to Tuesday, February 25, 2020 (All day)
02-28_Red_Cloud_Pre-PDAC_Mining-Showcase_Website

Red Cloud Pre-PDAC Mining Showcase

Friday, February 28, 2020 (All day)
PDAC_2020_Header

PDAC 2020

Sunday, March 1, 2020 (All day) to Wednesday, March 4, 2020 (All day)

Advertisement

Publicité